This trial is investigating whether personalized recommendations for the drug metoprolol, based on a patient's genetic makeup, will be more effective in reducing postoperative atrial fibrillation than the standard dosing recommendations.
- Post-operative Atrial Fibrillation
1 Primary · 8 Secondary · Reporting Duration: From end of surgery to hospital discharge; usually 3-4 days
1 Treatment Group
Pharmacogenetic-guided metoprolol management
1 of 1
107 Total Participants · 1 Treatment Group
Primary Treatment: Guided Metoprolol Management · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 2 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is enrollment available for this clinical trial?
"Affirmative. According to the information on clinicaltrials.gov, recruitment is currently underway for this medical trial which was first posted on March 5th 2021 and recently modified on March 10th 2022. The study needs 400 participants from one site in order to reach completion." - Anonymous Online Contributor
What is the estimated size of participation in this medical experiment?
"Yes, the information confirms that this clinical trial is still in search of volunteers. First posted on March 5th 2021 and most recently updated on March 10th 2022, 400 individuals are needed to participate at a single location." - Anonymous Online Contributor